Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)

被引:33
|
作者
Fortunati, N
Fissore, F
Fazzari, A
Piovano, F
Catalano, MG
Becchis, M
Berta, L
Frairia, R
机构
[1] Univ Turin, Lab Endocrinol, UOADU Med Gen 2, Azienda Osped S Giovanii Bta, I-10126 Turin, Italy
[2] Univ Turin, Dipartimento Fisiopatol Clin, I-10126 Turin, Italy
关键词
D O I
10.1016/S0960-0760(99)00092-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasma sex hormone-binding globulin (SHBG or SEP), the specific carrier for estradiol and androgens, after binding to its membrane receptor (SHBG-R), causes a significant increase of cAMP in the presence of estradiol, in both breast (MCF-7) and prostate (LNCaP) cancer cells maintained in serum-free medium. On the other hand, it has been proposed that estrogens, in addition to the well-known nuclear receptor pathway, exert their biological effect inducing cAMP, as a consequence of a direct membrane action, in breast cancer and uterine cells. The aim of the present study was to clarify this controversial issue by verifying if the cAMP increase in MCF-7 cells was a direct effect of estradiol, or if it was mediated by FCS proteins, such as bovine sex hormone-binding globulin; and to reevaluate the effect of human SHBG on cAMP induction in the presence of FCS. MCF-7 cells were maintained in DCC-FCS (treated with DCC to remove steroids), in SHBG-FREE/DCC-FCS (treated with DCC and with a specific affinity chromatography to remove bovine sex hormone-binding globulin), or in serum-free medium (SFM). It was observed that estradiol determined a significant time-dependent increase of cAMP only in MCF-7 cells maintained in 10% DCC-FCS. When cells were maintained in 10% SHBG-FREE/DCC-FCS, estradiol had no detectable effect. However, its ability to increase cAMP was observed again after the addition of human SHBG, in doses ranging from 5 to 50 nM. Moreover, in the presence of 10% SHBG-FREE/DCC-FCS, SHBG, even in the absence of estradiol, caused a significant increase of cAMP. In conclusion, the data reported in the present study suggest that the ability of estradiol to induce cAMP in MCF-7 cells is not due to a direct membrane effect of the hormone, but rather it is mediated by FCS. SHBG is one of the serum factors mediating estradiol action. Lastly, it was proven that SHBG triggers the cAMP pathway in MCF-7 cells in a physiologic culture condition and at physiologic concentrations. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [31] Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer
    Försti, A
    Jin, QR
    Grzybowska, E
    Söderberg, M
    Zientek, H
    Sieminska, M
    Rogozinska-Szczepka, J
    Chmielik, E
    Utracka-Hutka, B
    Hemminki, K
    CARCINOGENESIS, 2002, 23 (08) : 1315 - 1320
  • [32] The relationship of sex hormone-binding globulin (SHBG) gene polymorphisms with serum SHBG level and metabolic syndrome in Chinese Han males
    Pang, Xiao-Na
    Yuan, Ying
    Sun, Yan
    Shen, Ji-Ping
    Zha, Xiao-Yun
    Hu, Yu
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 26 (06) : 583 - 589
  • [33] VALIDITY OF THE CALCULATION OF NON-SEX HORMONE-BINDING GLOBULIN-BOUND ESTRADIOL FROM TOTAL TESTOSTERONE, TOTAL ESTRADIOL AND SEX HORMONE-BINDING GLOBULIN CONCENTRATIONS IN HUMAN-SERUM
    BELGOROSKY, A
    ESCOBAR, ME
    RIVAROLA, MA
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 28 (04): : 429 - 432
  • [34] Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells
    Fortunati, N
    Becchis, M
    Catalano, MG
    Comba, A
    Ferrera, P
    Raineri, M
    Berta, L
    Frairia, R
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6): : 473 - 479
  • [35] Serum concentration of sex hormone-binding globulin in healthy volunteers and patients with breast cancer stratified by sex and age
    Park, Se Jung
    Kim, Tae Soo
    Park, Kyu Hyun
    Kwon, Woo Sun
    Kim, Jin Ju
    ONCOLOGY LETTERS, 2020, 20 (01) : 364 - 372
  • [36] INTRACELLULAR SEX HORMONE-BINDING GLOBULIN (SHBG) IN NORMAL AND NEOPLASTIC BREAST-TISSUE - AN ADDITIONAL MARKER FOR HORMONE DEPENDENCY
    MEYER, S
    BRUMM, C
    STEGNER, HE
    SINNECKER, GHG
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1994, 102 (04): : 334 - 340
  • [37] Steroid-binding characteristics of sex hormone-binding globulin (SHBG) in carp, Cyprinus carpio
    Okunaga, M
    Matsubara, T
    Ohkubo, N
    Nagae, M
    FISH PHYSIOLOGY AND BIOCHEMISTRY, 2003, 28 (1-4) : 219 - 220
  • [38] DIFFERENTIAL BINDING OF TESTOSTERONE(T) AND ESTRADIOL(E2) TO ISOFORMS OF HUMAN SEX HORMONE-BINDING GLOBULIN (SHBG) - SELECTIVE CHANGES IN ESTRADIOL BINDING IN CIRRHOSIS
    PARDRIGE, WM
    TERASAKI, T
    NOWLIN, DM
    CLINICAL RESEARCH, 1988, 36 (03): : A554 - A554
  • [39] Identification of Common Variants on the SHBG Gene Affecting Sex Hormone-Binding Globulin Levels and Breast Cancer Risk in Postmenopausal Women
    Thompson, Deborah J.
    Healey, Catherine S.
    Baynes, Caroline
    Kalmyrzaev, Bolot
    Ahmed, Shahana
    Dowsett, Mitch
    Folkerd, Elizabeth
    Luben, Robert N.
    Cox, David
    Ballinger, Dennis
    Pharoah, Paul D. P.
    Ponder, Bruce A. J.
    Dunning, Alison M.
    Easton, Douglas F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (12) : 3490 - 3498
  • [40] CHANGES IN SERUM SEX HORMONE-BINDING GLOBULIN, FREE ESTRADIOL, AND TESTOSTERONE DURING GONADOTROPIN TREATMENT
    BENRAFAEL, Z
    MASTROIANNI, L
    MELONI, F
    STRAUSS, JF
    FLICKINGER, GL
    FERTILITY AND STERILITY, 1986, 46 (04) : 593 - 598